Concepedia

Author

S. Palmeri

University of Palermo

Also Known As

N Gebbia, Palmeri S., S PALMERI, S Palmeri, S. PALMERI, S. Palmeri, SERGIO PALMERI, Sergio Palmeri, V Adamo

114

Publications

1.3K

Citations

19

H-Index

39

Concepts

All Affiliations

University of PalermoTumour Institute of TuscanyIstituti di Ricovero e Cura a Carattere ScientificoOspedale S.GennaroUniversity of Sassari
SP

About

S. Palmeri is an author at University of Palermo specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

19

427

2

Health Sciences

2

2

44

3

Immunology

2

2

24

4

Gastroenterology

1

1

24

5

Hepatology

1

1

15

S. Palmeri

×

28

Publications

678

Citations

16

H-Index

YearCitations

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site

S. Palmeri, Vito Lorusso, Laura Palmeri,

Cancer

2006

51

Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401

Pasquale Comella, B. Massidda, Gianfranco Filippelli,

Journal of Cancer Research and Clinical Oncology

2008

51

Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial

P. Comella, B. Massidda, Gianfranco Filippelli,

Annals of Oncology

2005

48

Efficacy of the combination of cisplatin with either gemcitabine and vinorelbine or gemcitabine and paclitaxel in the treatment of locally advanced or metastatic non-small-cell lung cancer: a phase III randomised trial of the Southern Italy Cooperative Oncology Group (SICOG 0101)

P. Comella, Gianfranco Filippelli, G. De Cataldis,

Annals of Oncology

2006

47

Cytokine Gene Polymorphisms and Breast Cancer Susceptibility

Letizia Scola, M. Vaglica, Antonino Crivello,

Annals of the New York Academy of Sciences

2006

45

Regulatory Cytokine Gene Polymorphisms and Risk of Colorectal Carcinoma

Antonino Crivello, Antonio Giacalone, M. Vaglica,

Annals of the New York Academy of Sciences

2006

45

Cancer patients as `experts' in defining quality of life domains. A multicentre survey by the Italian Group for the Evaluation of Outcomes in Oncology (IGEO)

Massimo Costantini, Emanuela Mencaglia, Paola Di Giulio,

Quality of Life Research

2000

36

Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial

Cesare Gridelli, François Perron, S. Palmeri,

Annals of Oncology

1996

33

Oral tegafur in the treatment of gastrointestinal tract cancers: a phase II study

S. Palmeri, Vittorio Gebbia, Anna Russo,

British Journal of Cancer

1990

24

Addition of either irinotecan or methotrexate to bolus5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: a randomised study by the Southern Italy Cooperative Oncology Group

P. Comella, E. Crucitta, Ferdinando De Vita,

Annals of Oncology

2002

24

Page 1